Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort
Diabetes Care · 01.03.2024 · 47 (3) · 491-500
DOI: 10.2337/dc23-0914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 18.01.2024. Verfasst von Brittney J Palermo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Larner College of Medicine, University of Vermont, Burlington, VT. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metabolic Syndrome, Stroke. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Aging (NIA), National Institutes of Health, Department of Health….
Themen: Diabetes mellitus, Schlaganfall
Abstract (Originalsprache)
OBJECTIVE Black Americans have a greater risk of type 2 diabetes than White Americans. The proinflammatory cytokine interleukin-6 (IL-6) is implicated in diabetes pathogenesis, and IL-6 levels are higher in Black individuals. This study investigated associations of IL-6 with incident diabetes and metabolic syndrome in a biracial cohort. RESEARCH DESIGN AND METHODS The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study enrolled 30,239 Black and White adults age ≥45 years in 2003–2007, with a follow-up ∼9.5 years later. Baseline plasma IL-6 was measured in 3,399 participants at risk of incident diabetes and 1,871 at risk of metabolic syndrome. Relative risk (RR) by IL-6 was estimated with modified Poisson regression for both groups. RESULTS Incident diabetes occurred in 14% and metabolic syndrome in 20%; both rates rose across IL-6 quartiles. There was a three-way interaction of IL-6, race, and central adiposity for incident diabetes (P = 8 × 10−5). In Black participants with and without central adiposity, RRs were 2.02 (95% CI 1.00–4.07) and 1.66 (1.00–2.75) for the fourth compared with first IL-6 quartile, respectively. The corresponding RRs were 1.73 (0.92–3.26) and 2.34 (1.17–4.66) in White participants. The pattern was similar for IL-6 and metabolic syndrome. CONCLUSIONS Although IL-6 was higher in Black than in White participants and those with central adiposity, the association of IL-6 with diabetes risk was statistically significant only among White participants without central adiposity. The association with metabolic syndrome risk was similarly stronger in low-risk groups. The results support the concept of interventions to lower inflammation in diabetes prevention, but to reduce race disparities, better biomarkers are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Larner College of Medicine, University of Vermont, Burlington, VT.
- Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT.
- Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT.
- Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD.
- Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
ORCID-Profile: Brittney J Palermo, Katherine S Wilkinson, Timothy B Plante, Charles D Nicoli, Suzanne E Judd, Debora Kamin Mukaz, D Leann Long, Nels C Olson, Mary Cushman
Förderung
- NIGMS NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Aging (NIA), National Institutes of Health, Department of Health…
- Larner College of Medicine, University of Vermont
- Vermont Center for Cardiovascular and Brain Health
Zitieren
APA
Palermo, B. J., Wilkinson, K. S., Plante, T. B., Nicoli, C. D., Judd, S. E., Kamin Mukaz, D., Long, D. L., Olson, N. C., & Cushman, M. (2024). Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort. Diabetes Care, 47(3), 491-500. https://doi.org/10.2337/dc23-0914
Vancouver
Palermo BJ, Wilkinson KS, Plante TB, Nicoli CD, Judd SE, Kamin Mukaz D, et al. Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort. Diabetes Care. 2024;47(3):491-500. doi:10.2337/dc23-0914
BibTeX
@article{Palermo2024,
author = {Palermo, Brittney J and Wilkinson, Katherine S and Plante, Timothy B and Nicoli, Charles D and Judd, Suzanne E and Kamin Mukaz, Debora and Long, D Leann and Olson, Nels C and Cushman, Mary},
title = {Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort},
journal = {Diabetes Care},
year = {2024},
volume = {47},
number = {3},
pages = {491--500},
doi = {10.2337/dc23-0914}
}
EUVIMED